PERRI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 171
EU - Europa 152
AS - Asia 35
AF - Africa 5
SA - Sud America 1
Totale 364
Nazione #
US - Stati Uniti d'America 167
IT - Italia 87
SE - Svezia 47
IN - India 18
CN - Cina 13
RO - Romania 5
CA - Canada 4
DE - Germania 4
GB - Regno Unito 3
MY - Malesia 3
TG - Togo 3
MK - Macedonia 2
SC - Seychelles 2
UA - Ucraina 2
AR - Argentina 1
FR - Francia 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 364
Città #
Chandler 41
Rome 36
Fairfield 21
San Paolo di Civitate 11
Ashburn 9
Princeton 9
Woodbridge 9
Lawrence 8
Wilmington 8
Houston 6
Millbury 6
Seattle 6
Ann Arbor 4
Cambridge 4
San Diego 4
San Mateo 4
Beijing 3
Delhi 3
Fremont 3
Hebei 3
Lomé 3
London 3
Padova 3
Toronto 3
Andover 2
Boston 2
Guangzhou 2
Mahé 2
Beograd 1
Caserta 1
Cecina 1
Colle Di Val D'elsa 1
Federal 1
Genova 1
Grafing 1
Hangzhou 1
Latina 1
Mountain View 1
Naples 1
New Delhi 1
Norwalk 1
Nuremberg 1
Ottawa 1
Redwood City 1
Riyadh 1
Sacramento 1
Thalmassing 1
Totale 237
Nome #
JCPyV NCCR analysis in PML patients with different risk factors: Exploring common rearrangements as essential changes for neuropathogenesis 51
X Seminar- PhD day. Science for Democracy- Democracy for Science. PhD day Infectious Diseases, Microbiology and Public Health. Istituto Superiore di Sanità. 49
Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease 47
Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia. A retrospective cohort study 46
Major reduction of NKT cells in patients with severe COVID-19 pneumonia 44
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia 42
Increased sCD163 and sCD14 plasmatic levels and depletion of peripheral blood pro-inflammatory monocytes, myeloid and plasmacytoid dendritic cells in patients with severe COVID-19 pneumonia 40
Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortality 39
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study 36
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine 10
Totale 404
Categoria #
all - tutte 796
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 796


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 0000 00 00 3633
2020/202159 31002 112 15 5938
2021/2022183 422715 2010 2713 155369
2022/2023147 22382314 1722 110 0000
Totale 404